PTN: Palatin Technologies, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 25.82
Enterprise Value ($M) 16.33
Book Value ($M) -11.38
Book Value / Share -0.71
Price / Book -2.27
NCAV ($M) -12.69
NCAV / Share -0.79
Price / NCAV -2.03

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.10
Return on Equity (ROE) -2.14

Liquidity (mrq)
Quick Ratio 0.95
Current Ratio 1.09

Balance Sheet (mrq) ($M)
Current Assets 12.25
Assets 13.55
Liabilities 24.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 4.85
Operating Income -33.49
Net Income -27.54
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -28.42
Cash from Investing -3.43
Cash from Financing 9.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 -31.74

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-09-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 83,759 349,414 23.97
2024-03-27 47,800 112,443 42.51
2024-03-26 45,643 187,139 24.39
2024-03-25 17,614 104,605 16.84

(click for more detail)

Similar Companies
OGEN – Oragenics, Inc. PHGE – BiomX Inc.
PLX – Protalix BioTherapeutics, Inc. TOVX – Theriva Biologics, Inc.
VCXB – 10X Capital Venture Acquisition Corp. III


Financial data and stock pages provided by
Fintel.io


Finpedia: Palatin Technologies